N-[5-[4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide
C22H21FN4O4S — CID 155297584
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide
N-[5-[4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide (PubChem CID 155297584) has the molecular formula C22H21FN4O4S and a molecular weight of 456.50 g/mol. Its IUPAC name is N-[5-[4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide.
Molecular Properties
| Compound Name | N-[5-[4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 155297584 |
| Molecular Formula | C22H21FN4O4S |
| Molecular Weight | 456.50 g/mol |
| Exact Mass | 456.13 |
| IUPAC Name | N-[5-[4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide |
| SMILES | O=C(Nc1cn2c(-c3ccc(C(=O)N4CCS(=O)(=O)CC4)cc3F)cccc2n1)C1CC1 |
| InChI | InChI=1S/C22H21FN4O4S/c23-17-12-15(22(29)26-8-10-32(30,31)11-9-26)6-7-16(17)18-2-1-3-20-24-19(13-27(18)20)25-21(28)14-4-5-14/h1-3,6-7,12-14H,4-5,8-11H2,(H,25,28) |
| InChIKey | KNFPOZGBFSBKBN-UHFFFAOYSA-N |
| XLogP | 2.36 |
| TPSA | 100.85 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.50 |
| LogP ≤ 5 | 2.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155297584 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.